Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E. V. Skazyvaeva"'
Autor:
A. V. Pushkina, A. B. Avalueva, I. G. Bakulin, A. A. Topanova, A. A. Murzina, S. I. Sitkin, I. V. Lapinsky, E. V. Skazyvaeva
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 6, Pp 496-504 (2019)
Rationale: Irritable bowel syndrome (IBS) is a multifactorial disease, the genetic aspect of which is being actively studied.Aim: To investigate functional polymorphism of the serotonin reuptake transporter (SERT) SLC6A4 gene of various clinical vari
Externí odkaz:
https://doaj.org/article/7491a7b4f2aa464e855a73ed336fe8de
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 76-80 (2017)
Preparations of 5-aminosalycil acid (Mesalazine) are used as the first-line therapy to induce remission if the UC activity is minimal and as the priority drugs for anti-recurrence therapy of patients with UC and are included in the Russian recommenda
Externí odkaz:
https://doaj.org/article/648c23471f0c4e0e90412afb39c1c5d1
Autor:
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler
Publikováno v:
Терапевтический архив, Vol 91, Iss 2, Pp 9-15 (2019)
The article is published based on the results of the Russian Consensus on the diagnosis and treatment of primary sclerosing cholangitis (PSC), discussed at the 44th annual Scientific Session of the CNIIG "Personalized Medicine in the Era of Standards
Externí odkaz:
https://doaj.org/article/369fbd970a524d809c932e64bb20426a
Autor:
O. M. Drapkina, L. B. Lazebnik, I. G. Bakulin, M. S. Zhuravleva, N. V. Bakulina, E. V. Skazyvaeva, S. I. Sitkin, M. I. Skalinskaya, O. I. Solovyeva, E. Yu. Eremina, S. V. Tikhonov, T. S. Fil', T. L. Pilat, Yu. G. Kuznetsova, R. A. Khanferyan, M. A. Livzan, M. F. Osipenko, D. I. Abdulganieva, L. V. Tarasova, A. I. Khavkin
Publikováno v:
Experimental and Clinical Gastroenterology. :4-32
Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea, and an important cause of nosocomial infection. Since the publication of the National Guidelines (2016, 2017), new data have been accumulated on the
Autor:
O. M. Drapkina, L. B. Lazebnik, I. G. Bakulin, E. V. Skazyvaeva, N. V. Bakulina, S. I. Sitkin, M. I. Skalinskaya, M. S. Zhuravleva, E. B. Avalueva, M. A. Livzan, D. S. Bordin, A. I. Khavkin
Publikováno v:
Experimental and Clinical Gastroenterology. :33-69
Clinical guidelines are intended for gastroenterologists, internists, and general practitioners and focus primarily on the management of patients with symptomatic uncomplicated diverticular disease, as well as on the primary and secondary prevention
Autor:
V E Syutkin, M G Efanov, R G Sayfutdinov, E Z Burnevitch, O V Knyazev, T M Ignatova, A O Bueverov, R B Alikhanov, S G Khomeriki, G G Karmazanovsky, Igor G. Nikitin, K L Raichelson, A I Parfenov, E A Belousova, E V Vinnitskaya, E. Yu. Eremina, I G Bakulin, Yu. V. Kulezneva, A R Reisis, D.T. Abdurakhmanov, V V Pavlenko, T N Lopatkina, E V Skazyvaeva, T P Nekrasova, Ильченко Людмила Юрьевна (Ru), L Yu Ilchenko, S D Podymova, Yu G Sandler, Sayar Abdulkhakov, T Yu Haimenova
Publikováno v:
Терапевтический архив, Vol 91, Iss 2, Pp 9-15 (2019)
The article is published based on the results of the Russian Consensus on the diagnosis and treatment of primary sclerosing cholangitis (PSC), discussed at the 44th annual Scientific Session of the CNIIG "Personalized Medicine in the Era of Standards
Autor:
M Iu, Serkova, M A, Urtenova, E I, Tkachenko, E B, Avalueva, S V, Orlov, S V, Ivanov, E A, Orishak, E V, Skazyvaeva
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (11)
The aim of the study was the improvement of technologies of treatment of patients with the lung cancer receiving chemotherapy on the basis of using with the complex therapy of the combined probiotic based on the Bacillus subtilis strain.30 patients w